- Home
- SNEX vs RNA Comparison
SNEX vs RNA Comparison
Compare SNEX & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNEX
- RNA
- Stock Information
- Founded
- SNEX 1924
- RNA 2012
- Country
- SNEX United States
- RNA United States
- Employees
- SNEX N/A
- RNA N/A
- Industry
- SNEX Investment Bankers/Brokers/Service
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- SNEX Finance
- RNA Health Care
- Exchange
- SNEX Nasdaq
- RNA Nasdaq
- Market Cap
- SNEX 3.3B
- RNA 3.7B
- IPO Year
- SNEX 1994
- RNA 2020
- Fundamental
- Price
- SNEX $123.82
- RNA $31.12
- Analyst Decision
- SNEX
- RNA Strong Buy
- Analyst Count
- SNEX 0
- RNA 10
- Target Price
- SNEX N/A
- RNA $65.80
- AVG Volume (30 Days)
- SNEX 242.6K
- RNA 1.3M
- Earning Date
- SNEX 02-05-2025
- RNA 03-07-2025
- Dividend Yield
- SNEX N/A
- RNA N/A
- EPS Growth
- SNEX 16.78
- RNA N/A
- EPS
- SNEX 8.38
- RNA N/A
- Revenue
- SNEX $106,994,400,000.00
- RNA $10,117,000.00
- Revenue This Year
- SNEX N/A
- RNA N/A
- Revenue Next Year
- SNEX $1.94
- RNA N/A
- P/E Ratio
- SNEX $14.77
- RNA N/A
- Revenue Growth
- SNEX 60.95
- RNA N/A
- 52 Week Low
- SNEX $64.03
- RNA $14.11
- 52 Week High
- SNEX $128.23
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- SNEX 67.39
- RNA 44.06
- Support Level
- SNEX $115.81
- RNA $31.14
- Resistance Level
- SNEX $121.97
- RNA $33.37
- Average True Range (ATR)
- SNEX 4.01
- RNA 1.67
- MACD
- SNEX 0.66
- RNA -0.16
- Stochastic Oscillator
- SNEX 80.60
- RNA 11.27
About SNEX StoneX Group Inc.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.